| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |